Morgan Stanley Direct Lending Fund Earnings Call Transcripts
Fiscal Year 2026
-
Q3 NII per share increased to $0.48, while NAV fell amid concentrated credit marks and the BrightPet restructuring. Lower fees begin in 2027, and a supplemental distribution adds $0.015 per share to Q4 payouts.
-
Net investment income covered the dividend, with portfolio health remaining solid and 95% of assets performing as underwritten. Non-accruals rose to 2.9% of the portfolio, but management remains confident in the dividend and outlook, supported by JV growth and active capital management.
-
The meeting confirmed a quorum and proceeded with the election of two directors and the ratification of the independent auditor. All proposals were approved by stockholders, and the meeting was adjourned.
-
Net investment income declined modestly to $0.47 per share due to lower base rates, but portfolio quality remained strong with non-accruals down to 1.5%. Share repurchases and JV deployment supported NAV and future income, while spreads and lender terms improved.
Fiscal Year 2025
-
Q4 net investment income was $0.49 per share, with strong portfolio performance and a focus on NAV protection. The distribution was reduced to $0.45 per share for Q1 2026, and a new joint venture is ramping up, expected to enhance earnings.
-
Net investment income remained steady at $0.50 per share as deal activity and portfolio diversification increased. Funding costs declined with a new CLO and repriced facility, while credit quality stayed strong despite isolated non-accruals.
-
Q2 saw stable net investment income of $0.50 per share, strong portfolio credit quality, and further optimization of the debt mix. Leadership transitions reinforced continuity, while new funding initiatives and a defensive sector focus position the portfolio for resilience.
-
Strong Q1 2025 results with net investment income of $0.52 per share and a well-diversified, defensive portfolio. Leverage increased to 1.11x, and the company remains selective amid tariff-driven market volatility, expecting M&A recovery later in 2025.
Fiscal Year 2024
-
Strong Q4 and full-year 2024 results featured stable NAV, robust credit quality, and prudent capital deployment. Portfolio grew 19% year-over-year, with high dividend coverage and a balanced debt structure. Optimism remains for M&A and LBO activity in 2025.